Menu
Close X
Nippon India Pharma Fund(IDCW)

Scheme Returns

-1.42%

Category Returns

0.83%

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(IDCW) -1.58 -0.69 -1.42 -0.66 50.36 14.35 24.32 22.93 20.56
Equity - Sectoral Fund - Pharma & Health Care -0.92 -1.04 0.83 4.60 48.37 25.00 34.86 22.27 17.61

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.


  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    20,084.63

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    108.3588

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High
  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    (040) 23311968

  • Email

    customercare@nipponindiaim.in

  • Website

    mf.nipponindiaim.com

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032

  • Phone

    (040) 23312454 23320751 23320752

  • Fax

    (040) 23311968

  • Email

    customercare@karvy.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Company Market Value hold percentage
Nippon India Liquid Fund-Direct Growth Plan 10014.74 1.41
Cipla Limited 30448.5 6.14
Dr. Reddy's Laboratories Limited 28379.35 5.72
Lupin Limited 36143.19 7.29
Torrent Pharmaceuticals Limited 11493.78 2.32
Abbott India Limited 17889.89 3.61
GlaxoSmithKline Pharmaceuticals Limited 2565.18 0.52
Sanofi India Limited 16313.58 3.29
Pfizer Limited 11076.45 2.23
AstraZeneca Pharma India Limited 638.93 0.1
JB Chemicals & Pharmaceuticals Limited 6617.69 1.35
Apollo Hospitals Enterprise Limited 21108.79 4.26
Orchid Pharma Limited 4999 1.01
Sun Pharmaceutical Industries Limited 68946.57 13.9
Aurobindo Pharma Limited 21820.5 4.4
Jubilant Pharmova Limited 2193.38 0.44
Zydus Lifesciences Limited 18662.47 3.76
Ajanta Pharma Limited 14321.34 2.89
Divi's Laboratories Limited 25114.16 5.06
Indoco Remedies Limited 5999.28 1.21
Fortis Healthcare Limited 16346.84 3.3
Syngene International Limited 6136.14 1.24
Concord Biotech Limited 4881.34 0.88
Healthcare Global Enterprises Limited 1275.18 0.26
Mankind Pharma Limited 16740.19 3.38
Alkem Laboratories Limited 14136.13 2.85
Tarsons Products Limited 1337.86 0.27
Net Current Assets -60.8 -0.01
Cash Margin - CCIL 68.45 0.01
Narayana Hrudayalaya Limited 18866.74 3.8
Thyrocare Technologies Limited 9146.16 1.84
MedPlus Health Services Limited 14851.76 2.99
Gland Pharma Limited 12750 2.57
Metropolis Healthcare Limited 3557.03 0.57
Triparty Repo 11721.61 2.36
Vijaya Diagnostic Centre Limited 17212.49 3.47

Divident Details

Scheme Name Date Dividend (%)
Nippon India Pharma Fund 05-03-2018 6
Nippon India Pharma Fund 05-03-2019 5
Nippon India Pharma Fund 02-03-2020 4.5
Nippon India Pharma Fund 01-03-2021 6
Nippon India Pharma Fund 28-02-2022 3.5
Nippon India Pharma Fund 26-02-2024 10

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 1637.91 -0.98 1.97 23.58 51.8 16.32
NIPPON INDIA PHARMA FUND - IDCW Option 200.85 -1.42 -0.66 20.09 50.36 14.35
UTI Healthcare Fund - Regular Plan - IDCW 682.85 -0.83 1.17 20.57 48.67 12.69

Other Funds From - Nippon India Pharma Fund(IDCW)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 50422.78 2.48 3.88 21.57 55.19 33.43
Nippon India Small Cap Fund - Growth Plan - Growth Option 46044.13 2.48 3.88 21.57 55.19 33.43
Nippon India Small Cap Fund - Growth Plan - Growth Option 45894.01 2.48 3.88 21.57 55.19 33.43
Nippon India Small Cap Fund - Growth Plan - Growth Option 45749.06 2.48 3.88 21.57 55.19 33.43
Nippon India Small Cap Fund - Growth Plan - Growth Option 43815.61 2.48 3.88 21.57 55.19 33.43
Nippon India Small Cap Fund - Growth Plan - Growth Option 41018.84 2.48 3.88 21.57 55.19 33.43
CPSE ETF 39197.32 1.81 7.46 55.74 100.88 52.6
Nippon India Small Cap Fund - Growth Plan - Growth Option 37374.4 2.48 3.88 21.57 55.19 33.43
Nippon India Small Cap Fund - Growth Plan - Growth Option 37319.33 2.48 3.88 21.57 55.19 33.43
Nippon India Small Cap Fund - Growth Plan - Growth Option 36539.55 2.48 3.88 21.57 55.19 33.43